RE:Fairly Optomistic HereIn fact there is now nearly 500mill shares on the market, about 80% of them are private shares (look at MKT cap vs MKT cap less private shares). These shares came in play with the latest PP, they had to raise funds to clear up the dept to CardiaQ and have some extra money to continue developping the products. So that makes 400mill new shares that came in the market lately, it explains the super high volume. Will they be able to survive long enough to get their product approval make it profitable?? I hope so, even though I have no shares right now.... maybe I should consider getting back in soon....